Caplight Directory>Investors>Medytox Venture Investment>Medytox-venture-investment


Medytox Venture Investment

Medytox Venture Investment

Seoul, Seoulmedytoxventure.com

Overview

Medytox Venture Investment is the corporate venture capital arm of Medytox, a biopharmaceutical company based in Seoul, South Korea. Founded in 2017, the firm actively invests in early-stage biotechnology and healthcare companies. Its investment focus includes new drug development, medical devices, diagnostics, cosmeceuticals, and functional foods, seeking to create synergies with its parent company. The firm is also an operator for the TIPS (Tech Incubator Program for Startup) program in Korea, which supports tech startups.

Portfolio Companies

7

Investments

CompanyDateStageLead
NEX-I, Inc.Aug 2025Series BCo-investor
Avelos TherapeuticsApr 2024Series BCo-investor
GPCR TherapeuticsNov 2023Series C ExtensionCo-investor
ZymediMay 2023Series A ExtensionCo-investor
NEX-I, Inc.Oct 2022Series ACo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersSeoul, Seoul
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.